首页> 外文OA文献 >Suppresion of estrogen receptor (ER) - positive breast cancer cells' resistance to antiestrogens by using combinations of 4-Hydrotamoxifen (OHT), a typical antiestrogen, with phosphatidylinositol 3-Kinase (PI3K) inhibitors

【2h】

Suppresion of estrogen receptor (ER) - positive breast cancer cells' resistance to antiestrogens by using combinations of 4-Hydrotamoxifen (OHT), a typical antiestrogen, with phosphatidylinositol 3-Kinase (PI3K) inhibitors

机译：抑制雌激素受体（ER） - 阳性乳腺癌细胞对抗雌激素的抗性通过4-Hydrotamoxifen（OHT），一种典型的抗雌激素，与磷脂酰肌醇3-激酶（pI3K）抑制剂的组合

页面导航

著录项
相似文献
相关主题

著录项

作者
Τσιριγώτη Χρυσούλα;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 el_GR
中图分类

相似文献

外文文献
中文文献
专利

1. Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21(WAF1) in estrogen receptor-positive breast cancer [J] . Maynadier Marie, Basile Ilaria, Gallud Audrey, Oncology reports . 2016 ,第2期

机译：蛋白酶体抑制剂和抗雌激素的联合治疗在雌激素受体阳性乳腺癌中具有p21（WAF1）介导的协同作用
2. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells. [J] . Chang HL, Sugimoto Y, Liu S, Anticancer Research: International Journal of Cancer Research and Treatment . 2009 ,第8期

机译：角质形成细胞生长因子（KGF）通过磷脂酰肌醇3-激酶（PI3K）/ Akt通路调节人乳腺癌细胞中的雌激素受体α（ER-alpha）表达和细胞凋亡。
3. A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine resistance in hormone receptor-positive breast cancer: a genomic algorithm-based treatment approach [J] . Anita Gul, Brain Leyland-Jones, Nandini Dey, American Journal of Cancer Research . 2018 ,第12期

机译：PI3K途径抑制剂与细胞周期途径抑制剂的组合可对抗激素受体阳性乳腺癌的内分泌抵抗：一种基于基因组算法的治疗方法
4. Multifaceted activities of class Ⅰ phosphatidylinositol 3-kinase inhibitor ZSTK474 on human breast cancer cells [C] . Xin Peng, Zhengming Wang, Chang Zhou, International Forum on Leading Edge Technologies on Crystallization Engineering and Pharmaceutics Development;Tianjin University;Tianjin Medical University . -1

机译：Ⅰ类磷脂酰肌醇3-激酶抑制剂ZSTK474对人乳腺癌细胞的多丝活动
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway [O] . Lin Chen, Guangsheng Yang, Hongming Dong 2019

机译：依维莫司通过抑制雷帕霉素（mTOR）途径的磷脂酰肌醇3-激酶（PI3K）/ Akt /哺乳动物靶标逆转ER +人乳腺癌细胞中的palbociclib耐药性。
7. Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer [O] . Marie Maynadier, Ilaria Basile, Audrey Gallud, 2016

机译：用蛋白酶体抑制剂和抗雌激素的组合处理具有由P21WAF1介导的协同作用，雌激素受体阳性乳腺癌
8. Type-I Insulin-Like Growth Factor Receptor (IGF1R)-Estrogen Receptor (ER) Crosstalk Contributes to Antiestrogen Therapy Resistance in Breast Cancer Cells. [R] . Fagan, D. 2013

机译：I型胰岛素样生长因子受体（IGF1R） - 雌激素受体（ER）串扰有助于乳腺癌细胞中的抗雌激素治疗抗性。

Suppresion of estrogen receptor (ER) - positive breast cancer cells' resistance to antiestrogens by using combinations of 4-Hydrotamoxifen (OHT), a typical antiestrogen, with phosphatidylinositol 3-Kinase (PI3K) inhibitors

著录项

相似文献

相关主题

期刊订阅